ACTIV COVID-19 Clinical Trials

COMMENTARY

The ACTIV COVID-19 Clinical Trials: 5 Things to Know

Elizabeth Higgs, MD, DTMH, MIA

Disclosures

November 12, 2021

Editorial Collaboration

Medscape &

The Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative is currently conducting clinical trials to advance COVID-19 vaccines and therapeutics to both prevent COVID-19 and treat mild to life-threatening COVID-19 infection. The mission of ACTIV is to reduce the morbidity and mortality from COVID-19 and to accelerate the end of the SARS-CoV-2 outbreak.

ACTIV is a public-private partnership led by the National Institutes of Health (NIH), which leverages scientific innovation from across US government agencies, private pharmaceutical companies, academia, and philanthropic foundations. The Foundation for the National Institutes of Health provides logistical and management support to ACTIV

To continue reading this article ...
or
Continue reading your article with a Medscape account

Join the Top Medical Resource for Physicians Today. Free Membership!
Recommendations

processing....